Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

X-FAB Earnings Release 2023

Oct 26, 2023

9898_10-q_2023-10-26_1def2b6b-50b7-4c8b-a9bb-fd4f44b22d4a.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Regulated Information

X-FAB Third Quarter 2023 Results

Intermediate declaration by the Board of Directors Tessenderlo, Belgium – October 26, 2023, 05.40 p.m. CEST

Highlights Q3 2023:

  • Revenue was USD 233.8 million, up 24% year-on-year (YoY) and 3% quarter-on-quarter (QoQ); including USD 10.4 million of revenues recognized over time according to IFRS 15
  • Continued strong growth in X-FAB's key end markets – automotive, industrial, and medical – up 31% YoY (excluding revenues recognized over time)
  • All-time high Microsystems (MEMS) revenues, up 33% YoY
  • EBITDA at USD 65.7 million compared to USD 9.2 million in Q3 2022
  • EBITDA margin of 28.1%, slightly above the guided 24-28%
  • EBIT was USD 43.9 million with an EBIT margin of 18.8%

Outlook:

Q4 2023 revenue is expected to come in within a range of USD 230-245 million with an EBITDA margin in the range of 25-29%. This guidance is based on an average exchange rate of 1.06 USD/Euro.

in millions of USD Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q3 y-o-y
growth
Automotive 83.8 89.7 98.3 96.9 104.4 120.9 131.1 135.3 40%
Industrial 39.7 41.4 42.5 46.7 42.3 46.9 51.3 53.7 15%
Medical 14.5 13.7 13.9 13.5 14.6 17.6 16.2 17.0 26%
Subtotal core 138.0 144.9 154.7 157.0 161.3 185.4 198.7 206.1 31%
business 80.1% 81.1% 81.9% 83.4% 87.9% 89.1% 90.8% 92.2%
CCC1 34.0 32.5 33.6 30.7 21.6 22.5 20.0 17.2 -44%
Others 0.3 1.2 0.6 0.6 0.7 0.2 0.2 0.2
Revenue* 172.3 178.7 188.8 188.3 183.6 208.1 218.9 223.5 19%

Revenue* breakdown per quarter:

1Consumer, Communications & Computer

in millions of USD Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q3 y-o-y
growth
CMOS 144.2 148.6 156.3 152.6 151.9 172.8 180.7 180.5 18%
Microsystems 17.5 17.9 19.8 18.4 19.5 22.2 20.8 24.4 33%
Silicon carbide 10.6 12.1 12.8 17.4 12.2 13.2 17.3 18.6 7%
Revenues* 172.3 178.7 188.8 188.3 183.6 208.1 218.9 223.5 19%

Business development

In the third quarter of 2023, X-FAB recorded total revenues of USD 233.8 million, up 24% year-on-year and up 3% quarter-on-quarter and in line with the guidance of USD 225-240 million. A portion of USD 10.4 million is attributable to the recognition of revenues over time mainly related to long-term contracts with customers in accordance with IFRS 15.

Revenues* in X-FAB's core markets – automotive, industrial, and medical – amounted to USD 206.1 million, up 31% year-on-year, representing a share of 92.2% of revenues.

Demand in X-FAB's key end markets remained strong. Third quarter bookings were USD 208.2 million. While this represents a decrease of 4% year-on-year and 6% quarter-on-quarter, the order intake does not fully reflect the demand. This is mainly related to X-FAB's long-term agreements (LTAs) with major customers. The quantities under these contracts are not included in the bookings. Due to X-FAB's high backlog, which amounted to USD 483.7 million at the end of the third quarter, LTA customers prefer not to place orders too far in advance while having secured their capacity via LTA.

In the third quarter, X-FAB's automotive business continued to grow strongly recording revenues* of USD 135.3 million. This is an increase of 40% compared to the same quarter last year, primarily driven by the production ramp of X-FAB's popular 180nm automotive process at X-FAB France. In the third quarter, 91% of the revenues generated by the French site were based on X-FAB technologies, compared to 56% in the third quarter last year. In addition, a car headlight application was a main contributor to X-FAB's automotive growth in the third quarter, boosting automotive prototyping revenues after a major development achievement. X-FAB offers the full range of technologies required for power systems, including high-voltage CMOS and silicon carbide applications, and is well positioned to support the transition to electric vehicles, a key long-term growth driver for X-FAB's automotive business.

Industrial revenues* for the third quarter were USD 53.7 million, up 15% year-on-year. The shift towards clean energy sources like wind and solar is driving growth of X-FAB's silicon carbide business, while X-FAB's expertise in sensing and actuating is key to applications supporting major trends such as factory automation as well as smart cities and buildings.

Third quarter SiC revenues* totaled USD 18.6 million, an increase of 7% year-on-year, whereas SiC wafer shipments went up 38% year-on-year. The stronger increase in wafer shipments is not reflected in the top line due to a higher portion of customers that source their own SiC raw wafers and consign them to X-FAB. Since the value added by X-FAB remains unaffected, this results in a lower total billing but higher profitability.

In the third quarter, medical revenues* were USD 17.0 million, up 26% year-on-year, primarily driven by a DNA sequencing application. X-FAB is leveraging its MEMS expertise in combination with CMOS for this type of applications and has evolved its MEMS business towards high value-added microsystems integrating a variety of functions. This enables the miniaturization of large diagnostic equipment to handheld or tabletop size. In the third quarter, X-FAB's Microsystems business set a new revenue* record of USD 24.4 million, an increase of 33% year-on-year, demonstrating that the realignment of this business unit towards system integration is gaining traction.

Third quarter CCC (Consumer, Communication & Computer) revenues* amounted to USD 17.2 million, down 44% year-on-year.

Prototyping revenues* in the third quarter came in at USD 27.4 million, up 20% year-on-year and flat sequentially.

in millions
of USD
Revenue Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Automotive Prototyping 3.3 4.7 3.5 3.9 6.2
Production 93.6 99.8 117.3 127.2 129.1
Industrial Prototyping 11.1 11.2 14.2 16.6 14.3
Production 35.6 31.1 32.7 34.8 39.4
Medical Prototyping 2.8 2.8 2.9 2.5 3.3
Production 10.7 11.8 14.7 13.7 13.7
CCC Prototyping 5.0 4.6 5.7 4.5 3.3
Production 25.7 17.1 16.8 15.4 13.9

Prototyping and production revenue* per quarter and end market:

As announced on October 18, 2023, X-FAB is set to receive subsidies of up to EUR 80 million as part of the Important Project of Common European Interest in Microelectronics and Communication Technologies (IPCEI ME/CT). The funding will be granted by the participating governments of France and Germany over a period of five years supporting innovation to advance European goals of digitalization, sustainability, and technological sovereignty. See press release for more information.

Operations update

With continued strong demand particularly for X-FAB's 200mm CMOS, silicon carbide and MEMS technologies, operational excellence and productivity improvements remained key to reliably serve customers. Supply and demand for X-FAB's 150mm CMOS technologies is meanwhile well balanced.

A major operational focus in the third quarter was the execution of X-FAB's capacity expansion program, across all its sites. Although lead times for the new equipment are still long, all projects are on schedule.

In the third quarter, capital expenditures came in at USD 84.0 million, down 20% against the previous quarter. Considering the planned equipment deliveries in the fourth quarter, total capital expenditures of 2023 are expected to come in at approximately USD 350 million. Major expenditures in the third quarter included the capacity expansion project at X-FAB Sarawak, Malaysia, the capacity conversion at X-FAB France as well as the expansion of X-FAB's SiC manufacturing line in Lubbock, Texas.

Financial update

Third quarter EBITDA was USD 65.7 million with an EBITDA margin of 28.1%, slightly above the guidance range of 24-28%. Excluding revenues recognized over time in accordance with IFRS 15, the EBITDA margin of the third quarter would have been 26.8%. Gross profit in the third quarter amounted to USD 69.7 million with a gross profit margin of 29.8%, which would have been 29.1% without revenues recognized over time. The third quarter's profitability was driven by economies of scale, a favorable product mix and good cost control.

Due to the natural hedging of X-FAB's business, profitability was unaffected by exchange rate fluctuations. At a constant USD/Euro exchange rate of 1.01 as experienced in the previous year's quarter, the EBITDA margin would have been 0.3 percentage points lower.

Cash and cash equivalents at the end of the third quarter amounted to USD 391.3 million, down 11.4% compared to the end of the previous quarter, which had been extraordinarily strong due to a major portion of prepayments received from customers with long-term agreements. In addition, the decrease in cash and cash equivalents was due to cash outflows related to investments made in the third quarter.

Management comments

Rudi De Winter, CEO of the X-FAB Group, said: "The third quarter was characterized by strong revenue growth in X-FAB's key end markets, with our automotive business again leading the way with a 40% year-onyear increase. The successful transformation of our business keeps contributing to increasing profitability, driven by economies of scale and a favorable product mix. A highlight of the third quarter was the record sales in our Microsystems business. I am very proud of the system integration capabilities and expertise that X-FAB has built up. It is now starting to pay off and offers great opportunities for the future across various end markets."

X-FAB Silicon Foundries SE | Press Release October 26, 2023

X-FAB Quarterly Conference Call

X-FAB's third quarter results will be discussed in a live conference call/webcast on Thursday, October 26, 2023, at 6.30 p.m. CEST. The conference call will be in English.

Please register here for the webcast (listen only). Please register here for the conference call (listen and ask questions).

The fourth quarter 2023 results will be communicated on February 8, 2024.

About X-FAB

X-FAB is the leading analog/mixed-signal and MEMS foundry group manufacturing silicon wafers for automotive, industrial, consumer, medical and other applications. Its customers worldwide benefit from the highest quality standards, manufacturing excellence and innovative solutions by using X-FAB's modular CMOS processes in geometries ranging from 1.0 µm to 110 nm, and its special silicon carbide and MEMS long-lifetime processes. X-FAB's analog-digital integrated circuits (mixed-signal ICs), sensors and microelectro-mechanical systems (MEMS) are manufactured at six production facilities in Germany, France, Malaysia and the U.S. X-FAB employs more than 4,200 people worldwide. For more information, please visit www.xfab.com.

X-FAB Press Contact

Uta Steinbrecher Investor Relations X-FAB Silicon Foundries +49-361-427-6489 [email protected]

Forward-looking information

This press release may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management's current intentions, beliefs or expectations relating to, among other things, X-FAB's future results of operations, financial condition, liquidity, prospects, growth, strategies or developments in the industry in which we operate. By their nature, forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results or future events to differ materially from those expressed or implied thereby. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.

Forward-looking statements contained in this press release regarding trends or current activities should not be taken as a report that such trends or activities will continue in the future. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless legally required. You should not place undue reliance on any such forward-looking statements, which speak only as of the date of this press release.

The information contained in this press release is subject to change without notice. No re-report or warranty, express or implied, is made as to the fairness, accuracy, reasonableness, or completeness of the information contained herein and no reliance should be placed on it.

Condensed Consolidated Statement of Profit and Loss

in thousands of USD Quarter
ended
30 Sep 2023
unaudited
Quarter
ended
30 Sep 2022
unaudited
Quarter
ended
30 Jun 2023
unaudited
Nine months
ended
30 Sep 2023
unaudited
Nine months
ended
30 Sep 2022
unaudited
Revenue* 223,452 188,336 218,870 650,431 555,831
Revenue recognized over time 10,360 0 8,261 18,622 0
Total revenue 233,812 188,336 227,131 669,052 555,831
Revenues in USD in % 57 59 56 56 59
Revenues in EUR in % 43 41 44 44 41
Cost of sales -164,147 -142,432 -159,492 -474,551 -420,724
Gross Profit 69,665 45,904 67,639 194,501 135,107
Gross Profit margin in % 29.8 24.4 29.8 29.1 24.3
Research and development expenses -10,782 -9,917 -12,905 -34,609 -30,596
Selling expenses -1,999 -1,844 -2,112 -6,307 -5,961
General and administrative expenses -11,583 -8,860 -11,961 -34,044 -28,087
Rental income and expenses from investment
properties
977 -328 390 3,438 151
Other income and other expenses -2,376 -34,897 -231 -864 -34,310
Operating profit 43,902 -9,943 40,820 122,115 36,304
Finance income 9,011 10,219 6,658 24,207 25,896
Finance costs -8,493 -13,690 -8,229 -26,977 -46,332
Net financial result 518 -3,471 -1,571 -2,770 -20,436
Profit before tax 44,420 -13,413 39,249 119,345 15,868
Income tax -2,747 -1,608 -548 3,747 -4,596
Profit for the period 41,673 -15,021 38,701 123,092 11,272
Operating profit (EBIT) 43,902 -9,943 40,820 122,115 36,304
Depreciation 21,808 19,123 21,465 63,891 56,372
EBITDA 65,711 9,180 62,284 186,006 92,676
EBITDA margin in % 28.1 4.9 27.4 27.8 16.7
Earnings per share at the end of period 0.32 -0.11 0.30 0.94 0.09
Weighted average number of shares 130,631,921 130,631,921 130,631,921 130,631,921 130,631,921
EUR/USD average exchange rate 1.08842 1.00955 1.08946 1.08330 1.06620

Amounts in the financial tables provided in this press release are rounded to the nearest thousand except when otherwise indicated, rounding differences may occur.

*excluding revenues recognized over time in accordance with IFRS 15

Condensed Consolidated Statement of Financial Position

in thousands of USD Quarter ended
30 Sep 2023
Quarter ended
30 Sep 2022
Year ended
31 Dec 2022
unaudited unaudited audited
ASSETS
Non-current assets
Property, plant, and equipment 653,024 419,827 460,126
Investment properties 7,319 7,952 7,675
Intangible assets 5,827 7,269 6,199
Other non-current assets 63 6 79
Deferred tax assets 79,155 44,912 67,977
Total non-current assets 745,387 479,967 542,056
Current assets
Inventories 260,961 204,278 214,435
Contract assets 26,027 0 0
Trade and other receivables 111,828 82,595 73,116
Other assets 52,005 47,118 56,025
Cash and cash equivalents 391,274 327,468 369,425
Total current assets 842,095 661,459 713,001
TOTAL ASSETS 1,587,482 1,141,425 1,255,057
EQUITY AND LIABILITIES
Equity
Share capital 432,745 432,745 432,745
Share premium 348,709 348,709 348,709
Retained earnings 141,904 -24,625 16,509
Cumulative translation adjustment -328 185 -226
Treasury shares -770 -770 -770
Total equity attributable to equity holders of the parent 922,260 756,243 796,967
Non-controlling interests 0 0 0
Total equity 922,260 756,243 796,967
Non-current liabilities
Non-current loans and borrowings 49,244 65,234 63,432
Other non-current liabilities and provisions 4,024 3,686 4,024
Total non-current liabilities 53,268 68,921 67,456
Current liabilities
Trade payables 69,811 41,282 53,654
Current loans and borrowings 214,778 191,519 233,513
Other current liabilities and provisions 327,365 83,460 103,467
Total current liabilities 611,954 316,261 390,634
TOTAL EQUITY AND LIABILITIES 1,587,482 1,141,425 1,255,057

Condensed Consolidated Statement of Cash Flow

in thousands of USD Quarter
ended
30 Sep 2023
unaudited
Quarter
ended
30 Sep 2022
unaudited
Quarter
ended
30 Jun 2023
unaudited
Nine months
ended
30 Sep 2023
unaudited
Nine months
ended
30 Sep 2022
unaudited
Income before taxes 44,420 -13,413 39,249 119,345 15,868
Reconciliation of net income to cash flow
arising from operating activities:
26,845 18,392 22,895 72,721 75,631
Depreciation and amortization, before effect of
grants and subsidies
21,808 19,123 21,465 63,891 56,372
Recognized investment grants and subsidies
netted with depreciation and amortization
-753 -820 -751 -2,241 -2,535
Interest income and expenses (net) -105 967 652 1,992 14,165
Loss/(gain) on the sale of plant, property, and
equipment (net)
-1,554 -1,822 -137 -3,174 -1,998
Other non-cash transactions (net) 7,448 945 1,666 12,252 9,628
Changes in working capital: -38,694 8,067 141,779 101,875 -45,451
Decrease/(increase) of trade receivables 3,206 7,883 -21,482 -39,277 -16,232
Decrease/(increase) of other receivables &
prepaid expenses
3,417 1,913 -7,006 -516 -4,804
Decrease/(increase) of inventories -13,049 -5,852 -12,303 -44,238 -23,263
Decrease/(increase) of contract assets -10,360 0 -15,667 -26,027 0
(Decrease)/increase of trade payables -19,254 -3,080 -8,175 -189 -8,436
(Decrease)/increase of other liabilities -2,653 7,203 206,411 212,123 7,284
Income taxes (paid)/received -2,874 -342 -401 -3,383 -557
Cash Flow from operating activities 29,697 12,704 203,522 290,558 45,491
Cash Flow from investing activities:
Payments for property, plant, equipment &
intangible assets
-83,964 -40,918 -104,498 -237,357 -126,524
Payments for investments 0 -204 0 0 -204
Payments for loan investments to related
parties
-61 -45 -41 -237 -193
Proceeds from loan investments related parties 44 70 42 206 230
Proceeds from sale of property, plant, and
equipment
1,805 1,887 208 3,499 2,115
Interest received 3,139 394 2,557 6,709 906
Cash Flow used in investing activities -79,038 -38,815 -101,732 -227,181 -123,670

Condensed Consolidated Statement of Cash Flow – con't

in thousands of USD Quarter
ended
30 Sep 2023
unaudited
Quarter
ended
30 Sep 2022
unaudited
Quarter
ended
30 Jun 2023
unaudited
Nine months
ended
30 Sep 2023
unaudited
Nine months
ended
30 Sep 2022
unaudited
Cash Flow from (used in) financing activities:
Proceeds from loans and borrowings 85,904 129,728 5,027 100,144 152,270
Repayment of loans and borrowings -79,067 -1,892 -13,870 -128,867 -6,062
Receipts of sale & leaseback arrangements 0 0 0 0 7,723
Payments of lease installments -1,530 -1,362 -1,273 -4,315 -4,379
Receipt of government grants and subsidies 0 512 0 0 512
Interest paid -1,892 -13,503 691 -4,460 -14,074
Distribution to non-controlling interests 0 0 0 0 -11
Cash Flow from (used in) financing activities 3,415 113,484 -9,425 -37,498 135,979
Effect of changes in foreign currency exchange
rates on cash
-4,587 -10,734 -855 -4,030 -20,519
Increase/(decrease) of cash and cash
equivalents
-45,926 87,373 92,365 25,879 57,800
Cash and cash equivalents at the beginning of
the period
441,786 250,828 350,276 369,425 290,187
Cash and cash equivalents at the end of
the period
391,274 327,468 441,786 391,274 327,468